282 related articles for article (PubMed ID: 22966084)
1. HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.
Yin L; Calvo-Calle JM; Dominguez-Amorocho O; Stern LJ
J Immunol; 2012 Oct; 189(8):3983-94. PubMed ID: 22966084
[TBL] [Abstract][Full Text] [Related]
2. A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.
Yin L; Stern LJ
J Immunol Methods; 2014 Apr; 406():21-33. PubMed ID: 24583195
[TBL] [Abstract][Full Text] [Related]
3. Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection.
Calvo-Calle JM; Strug I; Nastke MD; Baker SP; Stern LJ
PLoS Pathog; 2007 Oct; 3(10):1511-29. PubMed ID: 17937498
[TBL] [Abstract][Full Text] [Related]
4. Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor.
Strug I; Calvo-Calle JM; Green KM; Cruz J; Ennis FA; Evans JE; Stern LJ
J Proteome Res; 2008 Jul; 7(7):2703-11. PubMed ID: 18507432
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: TCR contacts as anchors: effects on affinity and HLA-DM stability.
Anderson MW; Gorski J
J Immunol; 2003 Dec; 171(11):5683-7. PubMed ID: 14634075
[TBL] [Abstract][Full Text] [Related]
6. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
[TBL] [Abstract][Full Text] [Related]
7. Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
Bioley G; Jandus C; Tuyaerts S; Rimoldi D; Kwok WW; Speiser DE; Tiercy JM; Thielemans K; Cerottini JC; Romero P
J Immunol; 2006 Nov; 177(10):6769-79. PubMed ID: 17082590
[TBL] [Abstract][Full Text] [Related]
8. Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4
Álvaro-Benito M; Morrison E; Ebner F; Abualrous ET; Urbicht M; Wieczorek M; Freund C
Cell Mol Immunol; 2020 Feb; 17(2):133-142. PubMed ID: 30467419
[TBL] [Abstract][Full Text] [Related]
9. Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO.
Kremer AN; van der Meijden ED; Honders MW; Goeman JJ; Wiertz EJ; Falkenburg JH; Griffioen M
Blood; 2012 Oct; 120(16):3246-55. PubMed ID: 22889757
[TBL] [Abstract][Full Text] [Related]
10. Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes.
Meiring HD; Kuipers B; van Gaans-van den Brink JA; Poelen MC; Timmermans H; Baart G; Brugghe H; van Schie J; Boog CJ; de Jong AP; van Els CA
J Immunol; 2005 May; 174(9):5636-43. PubMed ID: 15843563
[TBL] [Abstract][Full Text] [Related]
11. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
[TBL] [Abstract][Full Text] [Related]
12. Short peptide sequences mimic HLA-DM functions.
Chou CL; Mirshahidi S; Su KW; Kim A; Narayan K; Khoruzhenko S; Xu M; Sadegh-Nasseri S
Mol Immunol; 2008 Apr; 45(7):1935-43. PubMed ID: 18054387
[TBL] [Abstract][Full Text] [Related]
13. HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.
Nanaware PP; Jurewicz MM; Leszyk JD; Shaffer SA; Stern LJ
Mol Cell Proteomics; 2019 Mar; 18(3):490-503. PubMed ID: 30573663
[TBL] [Abstract][Full Text] [Related]
14. Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+ and CD4+ T cell epitopes in a large dataset.
Wang S; Li J; Chen X; Wang L; Liu W; Wu Y
Immunol Res; 2016 Aug; 64(4):908-18. PubMed ID: 27094547
[TBL] [Abstract][Full Text] [Related]
15. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.
Poluektov YO; Kim A; Hartman IZ; Sadegh-Nasseri S
PLoS One; 2013; 8(8):e71228. PubMed ID: 23951115
[TBL] [Abstract][Full Text] [Related]
16. Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses.
Mitra-Kaushik S; Cruz J; Stern LJ; Ennis FA; Terajima M
J Immunol; 2007 Jul; 179(2):1303-12. PubMed ID: 17617623
[TBL] [Abstract][Full Text] [Related]
17. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
Singh N; Van Kaer L
J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
[TBL] [Abstract][Full Text] [Related]
18. Epitope Selection for HLA-DQ2 Presentation: Implications for Celiac Disease and Viral Defense.
Hung SC; Hou T; Jiang W; Wang N; Qiao SW; Chow IT; Liu X; van der Burg SH; Koelle DM; Kwok WW; Sollid LM; Mellins ED
J Immunol; 2019 May; 202(9):2558-2569. PubMed ID: 30926644
[TBL] [Abstract][Full Text] [Related]
19. The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes.
Kerzerho J; Schneider A; Favry E; Castelli FA; Maillère B
J Biol Chem; 2013 May; 288(19):13370-7. PubMed ID: 23553629
[TBL] [Abstract][Full Text] [Related]
20. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.
Reyes-Vargas E; Barker AP; Zhou Z; He X; Jensen PE
J Biol Chem; 2020 Mar; 295(10):2959-2973. PubMed ID: 31969393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
